Valens Company Reports Q3 Revenues Of $18.1 Million, Loss Of $3.1 Million
The Valens Company (TSX: VLNS) reported its third quarter financial results for the period ended August 31, 2020 this evening,
Read more
The Valens Company
Valens Sees Eight Capital, Haywood, Canaccord Slash Price Targets Following Q2 Financials
Last Wednesday, The Valens Company (TSX: VLNS) released its financial statements for the second quarter of 2020. Reported revenue came
Read more
Canaccord Resumes Coverage On The Valens Company, Issues $6.50 Price Target
This morning Canaccord Genuity resumed coverage on The Valens Company (TSX: VLNS) with a C$6.50 price target and Speculative Buy
Read more
Harvest Moon: Valens Company VS Medipharm Labs – Share Price Indicators
Of the 100 companies in the BI Global Cannabis Competitive Peers index tracked in 2019, The Valens Company (TSX: VLNS)
Read more
Valens Signs New Contract Manufacturing Agreement
The Valens Company (TSX: VLNS) appears to be pulling ahead as the premier cannabis extractor as of late, this morning
Read more
Raymond James Initiates Coverage On The Valens Company, Gives $4 Price Target
This morning Raymond James initiated coverage on The Valens Company (TSX: VLNS) with a C$4 price target and Outperform rating.
Read more
Valens Company Secures $40 Million In Debt Financing
The Valens Company (TSX: VLNS) has obtained up to $40 million in secured debt financing as of this morning. The
Read more
Valens Reports Q1 Revenue of $31.9 Million, Announces TSX Listing Date
The Valens Company (TSXV: VLNS) reported its first quarter 2020 financials after the bell today, electing to break trend from
Read more
Smokeless Cannabis Category Sales Surge On Quarantine Measures
No one wants cannabis beverages. Or, at least that’s the line long time cannabis enthusiasts have been touting for ages
Read more
Valens Company Granted Conditional Approval to Uplist to TSX
The Valens Company (TSXV: VLNS) has been granted conditional approval to uplist to the Toronto Stock Exchange from the TSX
Read more